Karuna Therapeutics, Inc.

99 High St Floor 26, Boston, MA 02110

Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients with schizophrenia; and for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company, and Zai Lab (Shanghai) Co., Ltd; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019.

Click to rate this company
[Total: 0 Average: 0]

2.6

Overall Excellence Rating

Industry

Healthcare

Category

Biotech & Pharmaceuticals

ESG/Ethical Impact

Karuna’s focus on drug development for neuropsychiatric disorders could indirectly contribute to environmental sustainability by advancing treatments that improve patients’ health and reduce the overall burden on healthcare systems. Sustainable Practices: The company might focus on efficient use of resources in its operations, such as energy-efficient facilities and sustainable supply chain practices.Inspire Medical Systems’ impact is amplified by its commitment to patient-centric healthcare solutions. The company’s innovative technologies empower patients with life-changing solutions that address critical medical needs. By providing solutions that improve patient outcomes and enhance quality of life, Inspire Medical Systems positively impacts patients, communities, and the broader healthcare landscape. Patient Well-Being: Karuna’s core business of developing therapies could have a significant positive impact on patient mental health and well-being, addressing unmet medical needs in the neuropsychiatric field. Mental Health Support: The company’s focus on neuropsychiatric disorders could contribute to accessible and advanced healthcare solutions for mental health.Clinical Standards: Adherence to ethical and clinical standards is essential for maintaining patient trust and regulatory compliance in drug development. Transparency: Karuna’s commitment to transparency and ethical conduct likely reflects in its corporate governance practices.Karuna’s financial sustainability comes from the development and potential commercialization of innovative therapies for neuropsychiatric disorders. Investor Relations: The company’s ESG efforts can influence investor perception, especially for those seeking investments aligned with ethical medical advancements.Karuna’s therapies directly impact patient lives by addressing serious mental health conditions and improving well-being. Investors: The company’s ESG initiatives can resonate with investors interested in both financial returns and ethical medical innovations.

Eligible Awards

Coming Soon







Claim Your Award Badges

Do you work with Us

Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer.

Awards Received

2023

Revenues

$11,000,000.00

Website Traffic

Employee Rating

3.9

Customer Rating

3.7

Company Size

100-1000

ESG Risk Rating

2

We’re Happy to Help.

Do you have questions about your ranking, our projects, or why you’re not on the list?
Scroll to Top

Excellence In My Industry

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business in your specific industry – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best Practice Certified

This badge tells your customers, employees, partners, and other stakeholders that your company has met the criteria of our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Best of Best Practices

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the top 20 companies in your industry that has met the criteria for our excellence certification in best practices across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.

Newsweek Excellence 1000

This badge tells your customers, employees, partners, and other stakeholders that your company is one of the Top 1000 companies that demonstrate excellence across all pillars of business – from financial responsibility and results, sustainability, social responsibility, employee experience, customer satisfaction, ethics, and more.